Chadi Nabhan, MD, MBA, FACP

Column

Prognostication and Treatment of Diffuse Large B-cell Lymphoma

12/05/2018

Journal of Clinical Pathways is pleased to present a new section called “CME Corner,” which will highlight, when available, relevant continuing medical education (CME) opportunities deemed to be of use to readers....

...

12/05/2018

Journal of Clinical Pathways

Research Reports

Community Oncologists` Perception and Acceptance of Biosimilars in Oncology

09/13/2018

Yolaine J. Jeune-Smith , PhD;

Amy Valley , PharmD;

Bruce A. Feinberg , DO;

Chadi Nabhan , MD, MBA, FACP;

Abstract: Biosimilars are hypothesized to contribute to lowering health care costs by entering the market at a discounted price compared with their reference biologics. Until recently, only filgrastim biosimilars...

...

09/13/2018

Journal of Clinical Pathways

Counterpoint

CAR-T Therapies: Placing Patient Safety First

08/22/2018

Chadi Nabhan , MD, MBA, FACP;

Bruce A. Feinberg , DO;

The commercial success and ability of eligible patients to receive chimeric antigen receptor T-cell (CAR-T) therapies depend on optimizing the logistics of delivering this transformational treatment platform. One...

The...

08/22/2018

Journal of Clinical Pathways

Research Reports

Community Oncologists‚ Perception and Adaptability to Emerging Chimeric Antigen T-Cell Therapy

10/16/2017

Bruce A. Feinberg , DO;

Chadi Nabhan , MD, MBA, FACP;

Yolaine J. Jeune-Smith , PhD;

Peter Klinefelter , BA;

Jennifer Fillman , MBA;

Abstract: The Oncologic Drugs Advisory Committee recently voted 10-0 recommending to the Food and Drug Administration (FDA) the approval of the first chimeric antigen receptor T (CAR-T) therapy. We sought to better...

...

10/16/2017

Journal of Clinical Pathways

Feature

Positioning CAR-T Therapy Into Clinical Pathways for Non-Hodgkin B-Cell Lymphoma and Beyond

03/23/2017

Sandeep Parsad , PharmD, BCOP;

Chadi Nabhan , MD, MBA, FACP;

Bruce A. Feinberg , DO;

Abstract: Enthusiasm for immunotherapy has spread throughout the oncology community in recent years, as therapies harnessing the body’s ability to fight cancers have offered the potential for remission and even cure...

...

03/23/2017

Journal of Clinical Pathways